Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Neoplasia ; 22(2): 61-75, 2020 02.
Article in English | MEDLINE | ID: mdl-31846834

ABSTRACT

Malignant cells ensure telomere maintenance by the alternative lengthening of telomeres (ALT) in the absence of telomerase activity (TA). The retrotransposons "long interspersed nuclear element-1" (LINE-1, L1) are expressed in malignant cells and are primarily known to contribute to complex karyotypes. Here we demonstrate that LINE-1 ribonucleoprotein particles (L1-RNPs) expression is significantly higher in ALT+- versus in TA+-human glioma. Analyzing a role of L1-RNP in ALT, we show that L1-RNPs bind to telomeric repeat containing RNA (TERRA), which is critical for telomere stabilization and which is overexpressed in ALT+ cells. In turn, L1-RNP knockdown (KD) abrogated the nuclear retention of TERRA, resulted in increased telomeric DNA damage, decreased cell growth and reduced expression of ALT characteristics such as c-circles and PML-bodies. L1-RNP KD also decreased the expression of Shelterin- and the ALT-regulating protein Topoisomerase IIIα (TopoIIIα) indicating a more general role of L1-RNPs in supporting telomeric integrity in ALT. Our findings suggest an impact of L1-RNP on telomere stability in ALT+ dependent tumor cells. As L1-RNPs are rarely expressed in normal adult human tissue those elements might serve as a novel target for tumor ablative therapy.


Subject(s)
DNA Topoisomerases, Type I/genetics , DNA-Binding Proteins/genetics , Glioma/genetics , Telomere/genetics , Transcription Factors/genetics , Cell Line, Tumor , DNA Damage/genetics , Glioma/pathology , Humans , Long Interspersed Nucleotide Elements/genetics , Ribonucleoproteins/genetics , Telomere Homeostasis/genetics
2.
Metallomics ; 11(12): 2010-2019, 2019 12 11.
Article in English | MEDLINE | ID: mdl-31593199

ABSTRACT

The scientific interest in cadmium (Cd) as a human health damaging agent has significantly increased over the past decades. However, particularly the histological distribution of Cd in human tissues is still scarcely defined. Using inductively coupled plasma-mass spectrometry (ICP-MS), we determined the concentration of Cd in 40 different human tissues of four body donors and provided spatial information by elemental imaging on the microscopic distribution of Cd in 8 selected tissues by laser ablation (LA)-ICP-MS. ICP-MS results show that Cd concentrations differ by a factor of 20 000 between different tissues. Apart from the well know deposits in kidney, bone, and liver, our study provides evidence that muscle and adipose tissue are underestimated Cd pools. For the first time, we present spatially resolved Cd distributions in a broad panel of human soft tissues. The defined histological structures are mirrored by sharp cut differences in Cd concentrations between neighboring tissue types, particularly in the rectum, testis, and kidneys. The spatial resolution of the Cd distribution at microscopic level visualized intratissue hot spots of Cd accumulation and is suggested as a powerful tool to elucidate metal based toxicity at histological level.


Subject(s)
Adipose Tissue/chemistry , Bone and Bones/chemistry , Cadmium/analysis , Kidney/chemistry , Liver/chemistry , Muscles/chemistry , Adipose Tissue/metabolism , Animals , Bone and Bones/metabolism , Cadmium/pharmacokinetics , Humans , Kidney/metabolism , Liver/metabolism , Male , Mass Spectrometry/methods , Muscles/metabolism , Rectum/chemistry , Rectum/metabolism , Reproducibility of Results , Testis/chemistry , Testis/metabolism , Tissue Distribution
3.
Cell Physiol Biochem ; 48(4): 1638-1651, 2018.
Article in English | MEDLINE | ID: mdl-30077999

ABSTRACT

BACKGROUND/AIMS: Clinical studies have reported a better outcome of smokers after myocardial infarction compared to non-smokers. The data are controversial, as some clinical studies did not observe this effect. The cell biological processes involved, which might account for a 'Smoker's Paradox', have not been investigated yet. Therefore, the aim was to elucidate the effect of cigarette smoke on the viability of cardiomyocytes in the context of hypoxia and reperfusion. METHODS: HL-1 cells were incubated with different concentrations of cigarette smoke extract (CSE) and subjected to hypoxia/reperfusion to further evaluate influence of CSE on viability of HL-1 cells using flow cytometry analyses, Western Blot and immunofluorescence staining. RESULTS: Incubation with CSE led to a concentration-dependent reduction in HL-1 viability. Adding hypoxia as a stressor enhanced cell death. Caspase-independent apoptosis was the observed type of cell death partly induced by P53 and apoptosis-inducing-factor. Yet a significant increase in LDH release in cardiomyocytes incubated with 4%, 8% and 16% CSE suggests necrosis with rapid DNA depletion. Interestingly, after hypoxia a decreased LDH release under lower CSE concentrations was observed. Moreover, a concentration-dependent increase in proliferation and a trend for increased ATP availability under hypoxic conditions was shown. CONCLUSIONS: The trend for less LDH release in hypoxia after low-level CSE incubation might represent a switch from necrosis to apoptosis, which in combination with the increase in metabolic activity and ATP availability might account for the 'Smoker's Paradox'. These findings could partly explain inconsistent results of previous clinical studies as the data showed strong evidence for the crucial relevance of the amount of cigarettes smoked. We are in need of future studies distinguishing between different types of smokers to finally verify or falsify the 'Smoker's Paradox'.


Subject(s)
Apoptosis , Smoke/adverse effects , Animals , Cell Hypoxia , Cell Line , DNA Damage , L-Lactate Dehydrogenase/metabolism , Mice , Microscopy, Electron, Scanning , Mitochondria/metabolism , Reactive Oxygen Species/metabolism , Receptor-Interacting Protein Serine-Threonine Kinases/metabolism , Tumor Suppressor Protein p53/metabolism
4.
Int J Cardiol ; 227: 717-726, 2017 Jan 15.
Article in English | MEDLINE | ID: mdl-27836291

ABSTRACT

BACKGROUND: Thoracic aortic aneurysm (TAA) is an often asymptomatic disease with fatal outcome, such as dissection or rupture. The megaaortic syndrome (MAS) is an extensive dilatation of the whole aorta with low incidence but high lethal outcome with unknown pathophysiology so far. METHODS AND RESULTS: We compared aortic tissue of patients with sporadic TAAs and MAS of the ascending aorta with non-aneurysmal control tissues. Specimens of MAS patients showed a significantly reduced thickness of the media but an increased thickness of the intima compared to control tissue and TAAs with moderate dilatation. Advanced media degeneration however was detectable in both, TAAs with enhanced luminal diameter and MAS specimens, accompanied by reduced medial smooth muscle cell-density. Further specimens of MAS were characterized by massive atherosclerotic lesions in contrast to specimens of sporadic TAA patients. Infiltrations of macrophages in atherosclerotic lesions but also in the media adjacent to the adventitia were significantly elevated in tissue of TAAs with dilatation ≤6cm. Of note, atherosclerotic plaque-associated macrophages as well as those in the external media produce huge amounts of MMP-9 which is possibly involved in media degeneration and tissue destruction. CONCLUSIONS: Taken together these results demonstrate that the pathology of MAS shows similarities with that of TAAs but pathological differences in the ascending aorta, suggesting that MAS might be a disease of different origin.


Subject(s)
Aorta/pathology , Aortic Aneurysm, Thoracic/pathology , Disease Progression , Aged , Aged, 80 and over , Aorta/surgery , Aortic Aneurysm, Thoracic/surgery , Dilatation, Pathologic/pathology , Dilatation, Pathologic/surgery , Female , Humans , Macrophages/pathology , Male , Middle Aged , Syndrome
5.
J Mol Cell Cardiol ; 99: 35-46, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27497529

ABSTRACT

The health benefit through the control of lipid levels in hyperlipidaemic individuals is evident from a large number of studies. The pharmacological options to achieve this goal shall be as specific and personalized as the reasons for and co-factors of hyperlipidaemia. It was the goal of this study to reveal the impact of leoligin on cholesterol levels and to define its mechanism of action. Oral application of leoligin in ApoE-/- mice led to significantly reduced total serum cholesterol levels and a reduction in postprandial blood glucose peak levels. In the absence of biochemical signs of toxicity, leoligin treatment resulted in reduced weight gain in mice. The effects of leoligin on serum cholesterol levels may be due to a direct inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) by a unique, non-statin-like binding mode. Postprandial serum glucose peaks may be reduced by a mild peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonistic activity of leoligin. No effect on atherosclerotic plaque size was observed. As a non-toxic, cholesterol-, peak glucose-, and weight gain-lowering compound, leoligin continues to fulfil characteristics of a potential agent for the treatment of cardiovascular disease (CVD). The counterregulatory overexpression of hepatic HMGCR in leoligin treated animals possibly explains the missing permanent anti-atherosclerotic effect.


Subject(s)
Apolipoproteins E/deficiency , Cholesterol/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Lignans/pharmacology , Plant Extracts/pharmacology , Animals , Cholesterol/blood , Female , Glucose/metabolism , Hydrogen Bonding , Hydroxymethylglutaryl CoA Reductases/chemistry , Hydroxymethylglutaryl CoA Reductases/metabolism , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/chemistry , Lignans/administration & dosage , Lignans/chemistry , Liver/drug effects , Liver/metabolism , Mice , Mice, Knockout , Models, Molecular , Molecular Conformation , PPAR gamma/agonists , PPAR gamma/chemistry , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Protein Binding , Protein Interaction Domains and Motifs , Structure-Activity Relationship , Time Factors
6.
Cell Mol Life Sci ; 73(8): 1699-713, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26588916

ABSTRACT

Apoptosis, necrosis, or autophagy-it is the mode of cell demise that defines the response of surrounding cells and organs. In case of one of the most toxic substances known to date, cadmium (Cd), and despite a large number of studies, the mode of cell death induced is still unclear. As there exists conflicting data as to which cell death mode is induced by Cd both across various cell types and within a single one, we chose to analyse Cd-induced cell death in primary human endothelial cells by investigating all possibilities that a cell faces in undergoing cell death. Our results indicate that Cd-induced death signalling starts with the causation of DNA damage and a cytosolic calcium flux. These two events lead to an apoptosis signalling-related mitochondrial membrane depolarisation and a classical DNA damage response. Simultaneously, autophagy signalling such as ER stress and phagosome formation is initiated. Importantly, we also observed lysosomal membrane permeabilization. It is the integration of all signals that results in DNA degradation and a disruption of the plasma membrane. Our data thus suggest that Cd causes the activation of multiple death signals in parallel. The genotype (for example, p53 positive or negative) as well as other factors may determine the initiation and rate of individual death signals. Differences in the signal mix and speed may explain the differing results recorded as to the Cd-induced mode of cell death thus far. In human endothelial cells it is the sum of most if not all of these signals that determine the mode of Cd-induced cell death: programmed necrosis.


Subject(s)
Apoptosis/drug effects , Autophagy/drug effects , Cadmium/toxicity , Human Umbilical Vein Endothelial Cells/drug effects , Membrane Potential, Mitochondrial/drug effects , Necrosis/pathology , Cadmium/metabolism , Calcium/metabolism , Cell Line , Cell Membrane Permeability/drug effects , Chelating Agents/metabolism , DNA Damage/drug effects , Egtazic Acid/metabolism , Gene Knockdown Techniques , Humans , Intracellular Membranes/metabolism , Lysosomes/pathology , Membrane Potential, Mitochondrial/physiology , Mitochondria/metabolism , Reactive Oxygen Species/metabolism , Tumor Suppressor Protein p53/metabolism
7.
Toxicol Sci ; 145(2): 360-71, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25770136

ABSTRACT

The deleterious effects of increased cadmium (Cd) serum levels on the cardiovascular system are proven by epidemiological and basic science studies. Cd exposure of animals and humans is known to impair myocardial function, possibly leading to heart failure. This study aims at investigating the effect of Cd treatment on the cardiac system with emphasis on the combined effect of Cd and high serum cholesterol levels as an important cardiovascular risk factor. Detailed analyses of Cd-induced effects on the heart of ApoE-/- mice fed a high fat diet (HFD), ApoE-/- mice fed a normal diet (ND), and C57BL/6J mice fed a ND revealed proinflammatory and fibrotic changes in the presence of cellular hypertrophy but in the absence of organ hypertrophy. Hypercholesterolemia in ApoE-/- mice alone and in combination with Cd treatment resulted in significant cardiomyocyte cell death. Based on further analyses of heart sections, we conclude that severe hypercholesterolemia in combination with ApoE-/- genotype as well as Cd treatment results in necrotic cardiomyocyte death. These data were supported by in vitro experiments showing a Cd-induced depolarization of the mitochondrial membrane and the permeabilization of the plasma membrane arguing for the occurrence of Cd-induced necrotic cell death. In summary, we were able to show for the first time that the combination of high cholesterol and Cd levels increase the risk for heart failure through cardiac fibrosis. This observation could in part be explained by the dramatically increased deposition of Cd in the hearts of ApoE-/- mice fed a HFD.


Subject(s)
Cadmium Chloride , Cardiomyopathies/chemically induced , Cholesterol/blood , Hypercholesterolemia/complications , Myocardium/pathology , Animals , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Biomarkers/blood , Body Burden , Cardiomyopathies/blood , Cardiomyopathies/pathology , Cell Line , Chemokine CCL2/metabolism , Diet, High-Fat , Disease Models, Animal , Female , Fibrosis , Hypercholesterolemia/blood , Hypercholesterolemia/genetics , Membrane Potential, Mitochondrial , Mice, Inbred C57BL , Mice, Knockout , Mitochondria, Heart/metabolism , Mitochondria, Heart/pathology , Myocardium/metabolism , Necrosis , Transforming Growth Factor beta/blood
8.
PLoS One ; 8(3): e58342, 2013.
Article in English | MEDLINE | ID: mdl-23554885

ABSTRACT

BACKGROUND: Insufficient angiogenesis and arteriogenesis in cardiac tissue after myocardial infarction (MI) is a significant factor hampering the functional recovery of the heart. To overcome this problem we screened for compounds capable of stimulating angiogenesis, and herein investigate the most active molecule, 5-Methoxyleoligin (5ML), in detail. METHODS AND RESULTS: 5ML potently stimulated endothelial tube formation, angiogenic sprouting, and angiogenesis in a chicken chorioallantoic membrane assay. Further, microarray- and knock down- based analyses revealed that 5ML induces angiogenesis by upregulation of CYP26B1. In an in vivo rat MI model 5ML potently increased the number of arterioles in the peri-infarction and infarction area, reduced myocardial muscle loss, and led to a significant increase in LV function (plus 21% 28 days after MI). CONCLUSION: The present study shows that 5ML induces CYP26B1-dependent angiogenesis in vitro, and arteriogenesis in vivo. Whether or not CYP26B1 is relevant for in vivo arteriogenesis is not clear at the moment. Importantly, 5ML-induced arteriogenesis in vivo makes the compound even more interesting for a post MI therapy. 5ML may constitute the first low molecular weight compound leading to an improvement of myocardial function after MI.


Subject(s)
Asteraceae/chemistry , Cytochrome P-450 Enzyme System/metabolism , Lignans/pharmacology , Myocardial Infarction , Myocardium/enzymology , Neovascularization, Physiologic/drug effects , Animals , Arterioles/enzymology , Arterioles/growth & development , Arterioles/pathology , Arterioles/physiopathology , Chick Embryo , Coronary Circulation/drug effects , Coronary Vessels/enzymology , Coronary Vessels/pathology , Coronary Vessels/physiopathology , Disease Models, Animal , Human Umbilical Vein Endothelial Cells , Humans , Lignans/chemistry , Male , Myocardial Infarction/drug therapy , Myocardial Infarction/enzymology , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocardium/pathology , Rats , Rats, Wistar , Retinoic Acid 4-Hydroxylase , Ventricular Function, Left/drug effects
9.
Atherosclerosis ; 220(2): 355-61, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22178424

ABSTRACT

OBJECTIVE: Past studies on the pathogenesis of thoracic aortic aneurysms have, by concentrating on histological and total tissue analyses, revealed several disease-relevant processes. Despite these studies, there is still a significant lack in the understanding of aneurysmal cell biology today. Hence, it was the goal of this study to assess differences between aneurysmal and healthy aortic smooth muscle cells (SMCs) on a broad - screening-like - basis, allowing us to formulate new hypotheses on the role of SMCs in thoracic aneurysm formation. METHODS AND RESULTS: After histological characterization of a total of 16 samples from healthy aortas and thoracic aortic aneurysms (TAA) of patients with bicuspid (BAV) and tricuspid (TAV) aortic valves, we isolated aortic SMCs and subjected them to cell biological and gene expression analyses. The data obtained indicate that aneurysmal SMCs exert reduced proliferation and migration rates compared to controls. BAV TAA SMCs have significantly shorter telomeres, whereas TAV TAA SMCs showed a reduced metabolic activity. In BAV TAA SMCs osteopontin (OPN) expression was significantly elevated, and TAV TAA SMCs showed decreased expression of tissue inhibitor of metalloproteinase 3 (TIMP3). CONCLUSION: Our study provides evidence that TAA-associated aortic wall disintegration in BAV and TAV TAAs shows similarities, but also significant differences. BAV and TAV TAAs differ with regard to medial elastic fiber mass and the occurrence of fibroblasts, SMC telomere length, metabolism, and gene expression. This study may form the basis for future in-depth analyses on the relevance of these findings in the pathophysiology of BAV and TAV TAAs.


Subject(s)
Aortic Aneurysm, Thoracic/etiology , Aortic Valve/abnormalities , Heart Defects, Congenital/complications , Muscle, Smooth, Vascular/pathology , Myocytes, Smooth Muscle/pathology , Adult , Aged , Aorta, Thoracic/metabolism , Aorta, Thoracic/pathology , Aortic Aneurysm, Thoracic/genetics , Aortic Aneurysm, Thoracic/metabolism , Aortic Aneurysm, Thoracic/pathology , Austria , Blotting, Western , Case-Control Studies , Cell Movement , Cell Proliferation , Cells, Cultured , Elastic Tissue/pathology , Fibroblasts/pathology , Gene Expression Profiling/methods , Gene Expression Regulation , Humans , Immunohistochemistry , Middle Aged , Muscle, Smooth, Vascular/metabolism , Myocytes, Smooth Muscle/metabolism , Osteopontin/genetics , Osteopontin/metabolism , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Telomere Shortening , Time Factors , Tissue Inhibitor of Metalloproteinase-3/genetics , Tissue Inhibitor of Metalloproteinase-3/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...